Xiao Ling-Yong, Li Zheng, Du Yu-Zheng, Shi Hui-Yan, Yang Si-Qi, Zhang Yue-Xin, Li Rui-Yu, Lin Wan-Ling, Wang He-Yang, Dai Xiao-Yu
Clinical Department of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, China.
Evid Based Complement Alternat Med. 2021 Oct 11;2021:8171636. doi: 10.1155/2021/8171636. eCollection 2021.
The aim of this study was to summarize and evaluate the efficacy of acupuncture in hypertension animal study.
Studies were searched from six databases, including Medline, Embase, Chinese National Knowledge Infrastructure, Wanfang Data, VIP information database, and Chinese Biomedical Literature Database. Study quality of each included study was evaluated according to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines, and the risk of bias was evaluated by the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were selected as outcomes. Meta-analyses were performed using Stata 12.0 software. The effect size was calculated by combining SBP/DBP/MAP data with the random effects model, respectively.
67 studies containing 1522 animals were included. According to the ARRIVE guideline, 8 items were assessed as poor and 4 items were assessed as excellent. According to the SYRCLE tool, all studies were judged as having high risk of bias. Compared with the hypertension group, the pooled results showed significant antihypertension effects of acupuncture for SBP, DBP, and MAP. Similarly, compared with the sham-acupuncture group, the pooled results showed significant antihypertension effects of acupuncture for SBP, DBP, and MAP.
Although pooled data suggested that the acupuncture group was superior to the hypertension group or sham-acupuncture group for SBP/DBP/MAP, the presentation of poor methodological quality, high risk of bias, and heterogeneity deserves cautious interpretation of the results.
本研究旨在总结和评估针刺在高血压动物研究中的疗效。
从六个数据库进行检索,包括医学文献数据库(Medline)、荷兰医学文摘数据库(Embase)、中国知网、万方数据、维普资讯数据库和中国生物医学文献数据库。根据《动物研究:体内实验报告规范》(ARRIVE)指南评估每项纳入研究的质量,并通过实验动物研究系统评价中心(SYRCLE)工具评估偏倚风险。选择收缩压(SBP)、舒张压(DBP)和平均动脉压(MAP)作为观察指标。使用Stata 12.0软件进行Meta分析。分别采用随机效应模型合并SBP/DBP/MAP数据计算效应量。
纳入67项研究,共1522只动物。根据ARRIVE指南,8项评估为差,4项评估为优。根据SYRCLE工具,所有研究均被判定为具有高偏倚风险。与高血压组相比,汇总结果显示针刺对SBP、DBP和MAP有显著的降压作用。同样,与假针刺组相比,汇总结果显示针刺对SBP、DBP和MAP有显著的降压作用。
尽管汇总数据表明针刺组在SBP/DBP/MAP方面优于高血压组或假针刺组,但方法学质量差、偏倚风险高和存在异质性等情况使得研究结果的解释应谨慎。